Keywords: agis, israel, sees, turnover, rise, boosted, pharma
Agis of Israel sees turnover rise of 10%, boosted by pharma performance
Article | 10 April 2000
Agis, the second-largest drugmaker in Israel (after Teva), had groupsales of 1.06 billion shekels ($263.8 million) in 1999, an increase of around 10% compared ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
